We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
ADLM 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

BD Presents Preanalytical Specimen Management Solutions

By LabMedica International staff writers
Posted on 29 Jul 2026

BD is highlighting preanalytical specimen management technologies and support services at ADLM 2026, held July 26–30 in Anaheim, California. At booth 2035, visitors can explore solutions designed to improve specimen quality and support evolving laboratory collection and processing needs.

The company’s exhibit focuses on preanalytical solutions for venous blood collection, urine collection, and blood gas analysis. These offerings are intended to help laboratories manage the critical steps that occur before testing and reduce variables that can affect the quality and reliability of diagnostic results.


Image: BD is highlighting its preanalytical solutions for venous blood collection, urine collection, and blood gas analysis (Photo courtesy of BD)
Image: BD is highlighting its preanalytical solutions for venous blood collection, urine collection, and blood gas analysis (Photo courtesy of BD)

BD is also presenting cell and biomarker preservation products intended to protect specimens between collection and analysis. Live demonstrations of the BD Learning Academy show how laboratories and healthcare professionals can access training resources, while an interactive station examines the future of specimen collection.

As part of its ADLM participation, BD is sponsoring the symposium “Quality in, Clarity Out: Improving Urine Culture Performance Through Multidisciplinary Interventions” on July 28 from 3:30 p.m. to 4:30 p.m. in Theater 3. The session examines a phased, multi-hospital study of strategies to reduce urine culture contamination, improve test quality, and support diagnostic stewardship.

The presentation also explores collaboration among clinical laboratories, frontline care teams, and industry partners. Data from the BD HealthSight MedMined database are used to evaluate outcomes before and after the interventions across multiple hospitals, including changes in antimicrobial use and Clostridioides difficile infection rates.

BD is additionally presenting two posters on July 28. One evaluates the within-tube stability of BD Vacutainer Rapid Serum Tubes for selected chemistry analytes and cardiac markers, while the second reviews urinalysis reflex-to-culture strategies and their impact on urine culture diagnostic stewardship and clinical outcomes.


New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Online QC Software
Acusera 24•7
HPV Molecular Test
BD Onclarity HPV Assay
New
Platelet Function Analyzer
PL-12

Latest ADLM 2026 News

Hettich Presents Small, Benchtop, and Automation-Ready Centrifuges
28 Jul 2026  |   ADLM 2026

Werfen Displays Complete Solutions for Hemostasis, Acute Care, Transfusion, and Transplant Solutions
28 Jul 2026  |   ADLM 2026

Tianlong Highlights Molecular Diagnostics and Blood Screening Solutions at ADLM 2026
28 Jul 2026  |   ADLM 2026



PURITAN MEDICAL